Abstract
Eight AIDS patients with Mycobacterium avium complex (MAC) bacteremia were randomized to receive azithromycin with or without granulocyte-macrophage colony-stimulating factor (GM-CSF) for 6 weeks to examine the effect of GM-CSF administration on clearance of mycobacteremia and on monocyte function. Superoxide anion production was significantly increased ex vivo in monocytes from patients receiving GM-CSF but not in those from patients receiving azithromycin alone. Relative to monocytes obtained from untreated healthy controls, median differences in viable intracellular MAC at 2, 4, and 6 weeks were -0.76, -0.94, and -0.47 log10 cfu/mL of lysate for cells from patients receiving GM-CSF versus -0.15, -0.11, and -0.19 log10 cfu/mL for cells from patients receiving azithromycin alone. Although no effect on mycobacteremia was detected, the administration of GM-CSF to AIDS patients with MAC bacteremia resulted in activation of their blood monocytes, as evidenced by increased superoxide anion production and enhanced mycobactericidal activity. GM-CSF deserves further investigation in the treatment of mycobacterial infections.
Citations
May 23, 2003·The Journal of Laboratory and Clinical Medicine·Daniel KaulPowel H Kazanjian
Jan 4, 2001·International Journal of Immunopharmacology·K N Masihi
Apr 25, 2000·International Journal of Antimicrobial Agents·K N Masihi
Jan 25, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·T C Jones
Dec 13, 2000·Microbes and Infection·S M Holland
Dec 13, 2005·Sexual Health·Anthony JaworowskiSteven L Wesselingh
Apr 21, 2005·MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports·Constance A BensonUNKNOWN Infectious Diseases Society of America
May 26, 2007·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Rajko Reljic
Jul 9, 1999·AIDS·S C Deresinski
May 5, 1999·Current Opinion in Hematology·T K Held, A S Cross
Jul 4, 2001·Journal of Virology·G M BahrY Mouton
Dec 1, 2001·Expert Opinion on Biological Therapy·K N Masihi
Jul 9, 2002·The Journal of Infection·Esteban C NanniniDimitrios P Kontoyiannis
Jan 2, 2007·The Journal of Infection·T I de SilvaJ M Greig
Oct 16, 2004·Expert Review of Anti-infective Therapy·Oliver KayserAlbrecht F Kiderlen
Feb 1, 2009·Expert Review of Respiratory Medicine·Rajko ReljicMauricio A Arias
Jul 7, 2018·Frontiers in Immunology·Benjamin G Chousterman, Marine Arnaud
Mar 21, 2020·Frontiers in Immunology·Champa N RatnatungaJohn J Miles